Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 3 | -$0.39 | -$0.39 | -$0.39 |
Q2 2024 | 1 | -$0.40 | -$0.40 | -$0.40 |
Q3 2024 | 4 | -$0.66 | -$0.33 | -$0.42 |
Q1 2025 | 3 | -$0.42 | -$0.35 | -$0.38 |
Q2 2025 | 2 | -$0.41 | -$0.41 | -$0.41 |
Q3 2025 | 2 | -$0.43 | -$0.43 | -$0.43 |
Q4 2025 | 2 | -$0.42 | -$0.42 | -$0.42 |
Centessa Pharmaceuticals plc last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-0.37 earnings per share for the quarter, topping analysts' consensus estimates of $-0.42 by $0.05. The company had revenue of 0 for the quarter and had revenue of 6.85 M for the year. Centessa Pharmaceuticals plc has generated $-2 earnings per share over the last year ($-1.57 diluted earnings per share) and currently has a price-to-earnings ratio of -12.35. Centessa Pharmaceuticals plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 27th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/12/2024 | Q3 2024 | -$0.42 | -$0.37 | 0.05 | $0 | $0 |
10/18/2024 | Q2 2024 | -$0.40 | $0 | $0 | ||
05/13/2024 | Q1 2024 | -$0.41 | -$0.38 | 0.03 | $0 | |
03/28/2024 | Q4 2023 | -$0.44 | -$0.38 | 0.06 | $6.91 M | |
11/13/2023 | Q3 2023 | -$0.46 | -$0.40 | 0.06 | $0 | |
08/14/2023 | Q2 2023 | -$0.43 | -$0.26 | 0.17 | $0 | |
05/12/2023 | Q1 2023 | -$0.41 | -$0.53 | -0.12 | $0 | |
03/30/2023 | Q4 2022 | -$0.48 | -$0.46 | 0.02 | $0 | |
11/10/2022 | Q3 2022 | -$0.49 | -$0.57 | -0.08 | $0 | |
08/10/2022 | Q2 2022 | -$0.56 | -$0.69 | -0.13 | $0 | |
05/16/2022 | Q1 2022 | -$0.70 | -$0.60 | 0.1 | $0 | |
03/30/2022 | Q4 2021 | -$0.60 | -$0.68 | -0.08 | $0 | |
11/15/2021 | Q3 2021 | -$0.55 | -$0.45 | 0.1 | $0 | |
08/16/2021 | Q2 2021 | -$0.73 | -$0.65 | 0.08 | $0 | |
03/30/2021 | Q1 2021 | -$2.75 | $0 | |||
12/30/2020 | Q4 2020 | -$0.22 | $0 | |||
09/29/2020 | Q3 2020 | -$0.02 | $0 | |||
06/29/2020 | Q2 2020 | $0.00 | $0 | |||
03/30/2020 | Q1 2020 | $0.00 | $0 |
Centessa Pharmaceuticals plc has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 27th, 2025 based off last year's report dates.
In the previous quarter, Centessa Pharmaceuticals plc (:CNTA) reported $-0.37 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.42 by $0.05.
The conference call for Centessa Pharmaceuticals plc's latest earnings report can be listened to online.
The conference call transcript for Centessa Pharmaceuticals plc's latest earnings report can be read online.
Centessa Pharmaceuticals plc (:CNTA) has a recorded annual revenue of $6.85 M.
Centessa Pharmaceuticals plc (:CNTA) has a recorded net income of $6.85 M. Centessa Pharmaceuticals plc has generated $-1.57 earnings per share over the last four quarters.
Centessa Pharmaceuticals plc (:CNTA) has a price-to-earnings ratio of -12.35 and price/earnings-to-growth ratio is -6.42.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED